Advanced gastric cancer remains a formidable clinical challenge, with treatment strategies continually evolving to improve patient outcomes. Recent advances have increasingly pivoted towards a ... Nutritional support in advanced gastric cancer patients enhances treatment continuity and predicts longer time to treatment failure, but not overall survival.
The study involved 324 patients, with 23% ... The American Journal of Managed Care: New Frontline Strategies for Advanced Gastric Cancer: Dani Castillo, MD Dani Castillo, MD, sheds light on the evolving landscape of first-line therapy in advanced gastric cancer. At the American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers Symposium, ... Managed Healthcare Executive: Asian patients respond better to immunotherapy for advanced HER2-negative gastric cancer Patients with advanced HER2-negative gastric cancer respond differently to immunotherapy based on whether they are Asian or non-Asian, with Asian patients often seeing better outcomes likely due to a ...
advanced gastric cancer treatment, The treatment goals and options for stomach cancer vary depending on how advanced the cancer is and how far it has spread. Surgery is often an effective treatment option for people with early-stage ... In patients with advanced Claudin-18 isoform 2 (CLDN18.2) -positive gastric or gastroesophageal junction cancers, satricabtagene autoleucel (satri-cel) chimeric antigen receptor (CAR) T-cell therapy ... News Medical: The impact of PD-1-positive immune cell ratios and TLS on gastric cancer treatment response The impact of PD-1-positive immune cell ratios and TLS on gastric cancer treatment response Precision oncology advancements have led to new treatment options for gastric cancer, including immunotherapy and targeted therapies like claudin 18.2-directed therapy. Biomarker testing is essential ...
